PMH40 - COST-MINIMISATION ANALYSIS OF SECOND GENERATION LONG ACTING INJECTABLES (RISPERIDONE , PALIPERIDONE, AND ARIPIPRAZOLE) FOR SCHIZOPHRENIA IN SPANISH MEDIUM-LONG TERM CARE PSYCHIATRIC UNITS
Abstract
Authors
E. Echarri A.I. Martinez F. Gutierrez I. De Sancho E. Lopez-lunar M.A. Iriarte E. Rodriguez-Garcia M. Martinez-deGuzman R.M. Provencio S. Sanz-Pamplona C. Gonzalez-Martin M. Longoni L. Carrillo P. Gonzalez-Hernandez